&quot;Ferrer Acquires Worldwide Rights to ASN90, an O-GlcNAcase Inhibitor From Asceneuron, Exclusively to Treat Progressive Supranuclear Palsy (PSP) https://t.co/Xubi1cItEb&quot;

ASN90 - Asceneuron

Feb 22, 2023